Roquefort Therapeutics plc (ROQ.L)

LSE • Currency in GBP

£1.55

+£0.25

+19.23%

Last Update: 7 Jul 2025, 15:35

£2.44M

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

£1.08 - £6.78

52 Week Range

ROQ.L Stock Price Chart

Explore Roquefort Therapeutics plc interactive price chart. Choose custom timeframes to analyze ROQ.L price movements and trends.

There is nothing to show.

ROQ.L Company Profile

Discover essential business fundamentals and corporate details for Roquefort Therapeutics plc (ROQ.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

22 Mar 2021

Employees

7.00

Website

https://www.roquefortinvest.com

CEO

Stephen Paul West CA

Description

Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

ROQ.L Financial Timeline

Browse a chronological timeline of Roquefort Therapeutics plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 28 Apr 2026

Upcoming earnings on 25 Sept 2025

Earnings released on 30 Apr 2025

Earnings released on 27 Sept 2024

EPS came in at -£0.00, while revenue for the quarter reached £2.70K.

Earnings released on 26 Apr 2024

EPS came in at -£0.01.

Earnings released on 27 Sept 2023

EPS came in at -£0.01, while revenue for the quarter reached £200.00K.

Earnings released on 5 Jun 2023

EPS came in at -£0.01.

Earnings released on 30 Jun 2022

EPS came in at -£0.02.

Earnings released on 31 Dec 2021

EPS came in at -£0.01, while revenue for the quarter reached £719.00.

Earnings released on 30 Jun 2021

EPS came in at -£0.02.

Earnings released on 30 Nov 2020

EPS came in at -£0.00.

ROQ.L Stock Performance

Access detailed ROQ.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.